SVA Share Price

Open 0.24 Change Price %
High 0.26 1 Day 0.02 8.33
Low 0.24 1 Week 0.00 0.00
Close 0.26 1 Month 0.02 8.33
Volume 71000 1 Year 0.04 18.18
52 Week High 0.40
52 Week Low 0.22
SVA Important Levels
Resistance 2 0.28
Resistance 1 0.27
Pivot 0.25
Support 1 0.25
Support 2 0.24
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
AZU 0.02 100.00%
AZU 0.02 100.00%
NMG 0.02 100.00%
NMG 0.02 100.00%
SSA 0.02 100.00%
ELT 0.02 100.00%
ELT 0.02 100.00%
DDX 0.50 100.00%
CPC 0.02 100.00%
CMV 0.02 100.00%
More..
CVE Canada Top Losers Stocks
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
LAK 0.02 -33.33%
SDS 0.02 -33.33%
More..

Sernova Corp (CVE: SVA)

SVA Technical Analysis 4
As on 24th Mar 2017 SVA Share Price closed @ 0.26 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.29 & Sell for SHORT-TERM with Stoploss of 0.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
SVA Target for March
1st Target up-side 0.27
2nd Target up-side 0.28
3rd Target up-side 0.29
1st Target down-side 0.23
2nd Target down-side 0.22
3rd Target down-side 0.21
SVA Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.sernova.com
SVA Address
SVA
700 Collip Circle
Suite 114
London, ON N6G 4X8
Canada
Phone: 519-858-5184
Fax: 519-858-5099
SVA Latest News
Sernova Announces Appointment of New CFO   Marketwired (press release)   - 30th Sep 16
JDRF backs Sernova's implant for T1D   Mass Device   - 08th Sep 16
Sernova And JDRF Announce Funding Of Joint Research Collaboration To Advance ...   Clinical Leader   - 13th Jul 16
Sernova and JDRF Announce Funding of Joint Research Collaboration to Advance ...   Yahoo Finance   - 12th Jul 16
Regenerative Medicine's Fountain of Youth   InvestorIdeas.com (press release)   - 26th Jan 16
How to Invest in a World Population Set to Reach 10 Billion People by 2050   Equities.com   - 22nd Jan 16
Funding Allows for the Clinical Development of New Cell-Based Hemophilia Therapy   Pharmaceutical Processing   - 22nd Dec 15
Sernova Receives Issued Patent in the United States for Its Cell Pouch™ and ...   Marketwired (press release)   - 23rd Apr 15
Has Sernova Found The Holy Grail Of Diabetes And Hemophilia?   Investing.com   - 27th Apr 14
Medical breakthrough   London Free Press   - 10th May 12
Interactive Technical Analysis Chart Sernova Corp ( SVA CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sernova Corp
SVA Business Profile
Sernova Corp., a clinical-stage health sciences company, focuses on the development and commercialization of medical technologies. The company’s proprietary platform technologies include Cell Pouch System, a scalable device providing a natural organ-like environment for therapeutic cells, such as insulin producing islets for diabetics; and Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. It also intends to commercialize the products for parkinson’s, spinal cord injury, and haemophilia diseases. The company is headquartered in London, Canada.